Clarification2 Jun 2026, 03:29 pm
Gufic Biosciences Clarifies Saraswat Bank Share Subscription
AI Summary
Gufic Biosciences Ltd has issued a clarification regarding its subscription to shares of Saraswat Co-operative Bank Limited. The company states that this subscription is not an acquisition or investment but is related to share-linkage requirements for borrower members, as mandated by RBI guidelines for co-operative banks. Gufic Biosciences is an existing borrower with credit facilities of approximately ₹230 crore. The subscription is within permissible limits and does not alter management, control, or voting rights, adhering to the 'one member, one vote' principle of Saraswat Bank.
Key Highlights
- Subscription to Saraswat Bank shares is for borrower linkage, not investment.
- Adheres to RBI guidelines for co-operative bank share capital.
- No change in management, control, or voting rights.
- Subscription is part of the lender-borrower relationship.
- Clarifies previous disclosure to avoid ambiguity.
Price Impact
More from GUFICBIO